Evidence map›Paper›PMID 22893480›Full record

ArticleThe journal of physiological sciences : JPS2013

Expression of specific IGFBPs is associated with those of the proliferating and differentiating markers in regenerating rat plantaris muscle.

Akihiko Yamaguchi, Kunihiro Sakuma, Takahiko Fujikawa, Isao Morita

Open access · goldAbstract read
In one paragraph

Article in The journal of physiological sciences : JPS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The therapeutic potential of IGF-I in skeletal muscle repair.Trends in endocrinology and metabolism: TEM · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Akihiko YamaguchiDepartment of Integrated Human Sciences, School of Dentistry, Health Sciences University of Hokkaido, Kanazawa, Ishikari-Tobetsu, Hokkaido, 061-0293, Japan. yama@hoku-iryo-u.ac.jp.
Kunihiro SakumaResearch Center of Physical Fitness, Sports and Health, Toyohashi University of Technology, Toyohashi, Aichi, Japan.
Takahiko FujikawaDepartment of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Isao MoritaDepartment of Integrated Human Sciences, School of Nursing and Social Services, Health Sciences University of Hokkaido, Kanazawa, Ishikari-Tobetsu, Hokkaido, Japan.
Health Sciences University of Hokkaido · JPSuzuka University of Medical Science · JPToyohashi University of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To examine the relationship between specific insulin-like growth factor (IGF)-binding proteins (IGFBPs) and myogenesis during muscle regeneration in vivo, we measured mRNA expression of IGFBPs and myogenic markers in rat plantaris muscle after bupivacaine administration. IGF-I Ea, MGF, IGFBPs and myogenic marker mRNAs were analyzed 12, 24, 48 and 72 h after bupivacaine injection. IGFBP-1, -2, -3 and -4 proteins were immunostained after the treatment. MGF, IGF-I Ea and IGFBP-4 mRNAs started to increase 12 or 24 h after bupivacaine injection and increased further after that. IGFBP-1, -2, -3 and -4 proteins were strongly stained in the immature muscle fiber nuclei and the extracellular matrix after bupivacaine injection. PCNA, MyoD, IGFBP-2 and IGFBP-3 mRNAs increased at 12 or 24 h and did not show further increases after that. Myogenin, p21, IGFBP-1 and IGFBP-5 mRNAs sharply increased after 72 h. These results suggest that specific IGFBPs are individually expressed and differently associated with the expression of myogenic markers in regenerating muscles.

Indexed as

AnimalsAntigens, DifferentiationCell DifferentiationCell ProliferationCyclin-Dependent Kinase Inhibitor p21Insulin-Like Growth Factor Binding ProteinsMaleMuscle DevelopmentMusclesMyoD ProteinMyogeninProliferating Cell Nuclear AntigenRatsRats, WistarRegenerationRNA, MessengerAntigens, DifferentiationCyclin-Dependent Kinase Inhibitor p21Insulin-Like Growth Factor Binding ProteinsMyoD ProteinMyogeninProliferating Cell Nuclear AntigenRNA, Messenger

Identifiers

PMID22893480
PMCPMC10717154
OpenAlexW2142858260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.